Dipentylone

Dipentylone is a psychoactive drug of the cathinone class that has been sold online as a designer drug. It is a higher homologue of pentylone. Dipentylone is a stimulant substance of the cathinone class that produces typical cathinone-class stimulant, entactogen, and hallucinogen effects when administered.
Chemistry[edit]
Dipentylone is a synthetic cathinone. Cathinones are structurally similar to amphetamines, they contain a phenethylamine core featuring a phenyl ring bound to an amino (NH2) group through an ethyl chain with an additional methyl substitution at Rα. Cathinones such as dipentylone are alpha-methylated phenethylamines (amphetamines). However, cathinones contain a ketone functional group at Rβ.
Pharmacology[edit]
The mechanism of action for dipentylone is not well understood. However, it is believed to work in a similar manner to other cathinones, acting as a norepinephrine-dopamine reuptake inhibitor (NDRI). This means it effectively increases the levels of the norepinephrine and dopamine neurotransmitters in the brain by binding to and partially blocking the transporter proteins that normally remove those monoamines from the synaptic cleft.
Effects[edit]
The effects of dipentylone can vary greatly depending on the dose, the individual's physiology, and the purity of the drug. Common effects reported by users include feelings of euphoria, increased sociability, mental and physical stimulation, and hallucinations at high doses. However, negative side effects can include insomnia, paranoia, and potentially dangerous increases in heart rate and blood pressure.
Legal Status[edit]
The legal status of dipentylone varies by country. In the United States, it is a Schedule I controlled substance. In the United Kingdom, it is a Class B drug under the Misuse of Drugs Act. In Canada, it is a Schedule I substance under the Controlled Drugs and Substances Act.
See Also[edit]
| Psychoactive substances | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This psychoactive substance-related article is a stub.
|
| Stimulants | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Empathogens/entactogens | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Controlled Substances | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This Controlled substances related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
